Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,991,053
+$1,708,684 QoQ
Shares Held
1,660
+440.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#2,505
of 4,605 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHASE INVESTMENT COUNSEL CORP holds $12,873,117 across 6 Drug Manufacturers - General names. LLY ranks #2 (15.5% of the industry book) .
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,991,053 | 1,660 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $282,369 | 307 | Shares | Sole | 2026-05-12 | |
| 2024-06-30 | $1,144,400 | 1,264 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $984,897 | 1,266 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||